Stereospecific reversal of stress-induced anhedonia by mianserin and its (+)-enantiomer

Psychopharmacology

Volumn 116, Issue 4, 1994, Pages 523-528

  Cheeta, Survjit ^a   Broekkamp, Chris ^b   Willner, Paul ^a  

^a SWANSEA UNIVERSITY   (United Kingdom)

^b NV Organon   (Netherlands)

Author keywords

(+) Mianserin; Anhedonia; Chronic mild stress; Dopamine; Mianserin; Place conditioning; Rat; Sucrose drinking

Indexed keywords

MIANSERIN; RACLOPRIDE; SUCROSE;

ANHEDONIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONDITIONING; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; ENANTIOMER; FOOD INTAKE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; RACEMIC MIXTURE; RAT; REWARD; STEREOSPECIFICITY; STRESS;

ANIMAL; CHOICE BEHAVIOR; EATING; FOOD DEPRIVATION; MALE; MIANSERIN; RACLOPRIDE; RATS; RECEPTORS, DOPAMINE D2; REWARD; SALICYLAMIDES; STEREOISOMERISM; STRESS, PSYCHOLOGICAL; SUCROSE; SUPPORT, NON-U.S. GOV'T; WATER DEPRIVATION;

EID: 0027985537     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/BF02247488     Document Type: Article

References (42)

1. Prolonged treatment with the specific 5-HT inhibitor citalopram: effects on dopaminergic and serotonergic functions
2. Blockade of presynaptic alpha receptors and of amine uptake in the rat brain by the antidepressant mianserin
3. Conditioned place preference as a measure of drug reward
4. Reversal of stress-induced anhedonia by mianserin and its (+)-enantiomer
5. Potential neuroleptics agents 4: chemistry, behavioural pharmacology, and inhibition of (3H)-spiperone binding of 3,5-disubsituted N-((1-ethyl-2-pyrrolidinyl)methyl)-6-methoxy-salicylates
6. Pharmaco-EEG study of 6-azamianserin (ORG 3770): dissociation of EEG and pharmacologic predictors on antidepressant activity
7. Decrease in hypothalamic epinephrine concentration and other neurochemical changes produced by quinpirole, a dopamine agonist, in rats
8. Comparison of the effects of mianserin and its enantiomers and metabolites on a behavioural screen for anti-depressant activity
9. The discovery of psychotropic drugs by computer-analyzed cerebral bioelectrical potentials (CEEG)
10. Behavioural pharmacology of antagonists of 5HT2/5-HT1c receptors
11. Repeated treatment with imipramine or amitriptyline increases the locomotor response of rats to (+)-amphetamine given into the nucleus accumbens
12. The influence of oxaprotaline enatiomers given repeatedly on the behavioural effects of d-amphetamine and dopamine injected into the nucleus accumbens
13. The central antiserotonergic action of mianserin
14. Repeated treatment with antidepressant drugs potentiates the locomotor response to (+)- amphetamine
15. Repeated treatment with antidepressant drugs increases the behavioural response to apormorphine
16. Desimpramine given repeatedly enhances behavioural effects of dopamine and d-amphetamine injected directly into the nucleus accumbens
17. Cholinergic-dopaminergic interactions and the mechanisms of action of antidepressants
18. Antidepressant treatment prevents chronic mild stress-induced anhedonia as assessed by ventral tegmentum self-stimulatio behaviour in rats
19. Effects of moclobemide, a new generation reversible MAO-A inhibitor, in a novel animal model of depression
20. Curative effects of the atypical antidepressant mianserin in the chronic mild stress-induced anhedonia model of depression
21. Suppression of sucrose drinking by chronic mild unpredictable stress: a methodological analysis
22. Changes in dopamine sensitivity in an animal model of depression
23. Dopaminergic mechanisms of imipramine action in an animal model of depression
24. Reversal of stress-induced anhedonia by the atypical antidepressants, fluoxetine and maprotiline
25. An animal model of anhedonia: attenuation of sucrose consumption and place preference conditioning by chronic unpredictable mild stress
26. Attenuation of place preference conditioning but not place aversion conditioning by chronic mild stress
27. Subsensitivity to rewarding and locomotor stimulant effects of a dopamine agonist following chronic mild stress
28. Parallel changes in dopamine D2 receptor binding in limbic forebrain associated with chronic mild stress-induced anhedonia and its reversal by imipramine
29. Pharmacological aspect of mianserin
30. The potential therapeutic role of the enantiomers and metabolites of mianserin
31. Reversal of antideperssant action by dopamine antagonists in an animal model of depression
32. Differences in presynaptic alpha-blockade, noradrenalin inhibition uptake and potential antidepressant activity between (+)- and (−)- mianserin
33. Molecular cloning and characterisation of a novel dopamine receptor (D3) as a target for neuroleptics
34. Voltammetric evidence that subsensitivity to reward following chronic mild stress is associated with increased release of mesolimbic dopamine
35. Mianserin, a really different antidepressant
36. Behavioural changes during withdrawl from the tricyclic antidepressant desmethylimipramine (DMI). I. Interactions with amphetamine
37. Reduction of sucrose preference by chronic mild stress and its restoration by a tricyclic antidepressant
38. Changes in mesolimbic dopamine may explain stress-induced anhedonia
39. Chronic mild stress-induced anhedonia: a realistic animal model of depression